Steve Schonfeld’s Adaptive Biotechnologies ADPT Stock Holding History

Steve Schonfeld’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	51,183 -211,016	-80%	-$3.23M	﹤0.01%	1432
2026 Q1	$3.64M	Buy	262,199 +151,747	+137%	+$2.42M	0.03%	592
2025 Q4	$1.79M	Buy	110,452 +89,508	+427%	+$1.46M	0.01%	917
2025 Q3	$313K	Buy	+20,944	New	+$255K	﹤0.01%	1834
2022 Q2	–	Sell	-26,500	Closed	-$368K	–	2479
2022 Q1	$368K	Sell	26,500 -9,700	-27%	-$153K	﹤0.01%	1549
2021 Q4	$1.02M	Buy	+36,200	New	+$1.11M	0.01%	928
2021 Q2	–	Sell	-29,112	Closed	-$1.17M	–	1900
2021 Q1	$1.17M	Buy	+29,112	New	+$1.58M	0.01%	828
2020 Q4	–	Sell	-50,000	Closed	-$2.43M	–	1531
2020 Q3	$2.43M	Buy	50,000 +28,900	+137%	+$1.21M	0.05%	454
2020 Q2	$1.02M	Buy	+21,100	New	+$769K	0.03%	593
2019 Q4	–	Sell	-29,900	Closed	-$925K	–	1268
2019 Q3	$925K	Sell	29,900 -86,945	-74%	-$3.55M	0.03%	483
2019 Q2	$5.64M	Buy	+116,845	New	+$5.18M	0.2%	124

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Steve Schonfeld's ADPT Position: Q2 2026 in Review

Steve Schonfeld reduced its Adaptive Biotechnologies (ADPT) stake by 80% in Q2 2026, selling an estimated $3.23M and leaving 51,183 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Steve Schonfeld first reported a position in ADPT in Q2 2019 and has held it in 11 quarters since. The position peaked at $5.64M in Q2 2019. 298 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Steve Schonfeld held 51,183 shares of Adaptive Biotechnologies worth $1.1M as of Q2 2026.
Steve Schonfeld sold 211,016 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.23M.
Adaptive Biotechnologies made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1432 holding.
Steve Schonfeld first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 11 quarters since.
Steve Schonfeld's Adaptive Biotechnologies position peaked at $5.64M in Q2 2019.
298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.